0,973  0,002  CYP1A2 substrate
0,968  0,001  Antiacne
0,962  0,002  AR expression inhibitor
0,962  0,002  CYP2C19 substrate
0,944  0,003  Carcinogenic
0,939  0,001  Retinoic acid receptor agonist
0,925  0,003  Antipsoriatic
0,923  0,003  Chemoprotective
0,918  0,003  Skin irritative effect
0,907  0,005  Apoptosis agonist
0,902  0,000  Alcohol dehydrogenase substrate
0,896  0,004  Embryotoxic
0,893  0,004  Teratogen
0,891  0,004  Mutagenic
0,873  0,002  Glutathione S-transferase substrate
0,852  0,005  CYP2C9 substrate
0,843  0,004  Eye irritation, high
0,843  0,004  Prostate cancer treatment
0,838  0,005  Radioprotector
0,831  0,002  ABCA1 expression enhancer
0,830  0,008  CYP3A4 substrate
0,811  0,001  Retinoic acid receptor gamma antagonist
0,805  0,001  Retinoic acid receptor antagonist
0,794  0,001  Retinoic acid beta receptor agonist
0,787  0,009  TNF expression inhibitor
0,789  0,014  Transcription factor NF kappa B inhibitor
0,777  0,004  Caspase 3 stimulant
0,776  0,005  Sensitization
0,765  0,004  Antineoplastic (brain cancer)
0,762  0,001  Retinoic acid alpha receptor antagonist
0,759  0,005  CYP2D6 substrate
0,745  0,001  Ornithine decarboxylase inhibitor
0,742  0,000  Aldehyde dehydrogenase substrate
0,731  0,003  Macular degeneration treatment
0,723  0,004  Skin whitener
0,725  0,017  Antineoplastic (breast cancer)
0,707  0,004  UGT1A1 substrate
0,707  0,005  Antioxidant
0,727  0,026  Antiinflammatory
0,693  0,001  Retinoic acid gamma receptor agonist
0,687  0,007  Proliferative diseases treatment
0,683  0,005  UDP-glucuronosyltransferase substrate
0,672  0,001  Retinoic acid beta receptor antagonist
0,655  0,001  Retinoic acid alpha receptor agonist
0,647  0,004  Liver fibrosis treatment
0,653  0,011  Chemopreventive
0,638  0,011  Bone diseases treatment
0,631  0,008  Antipruritic, allergic
0,621  0,003  Neurotrophic factor
0,603  0,004  Aldehyde dehydrogenase inhibitor
0,601  0,010  Antiosteoporotic
0,587  0,010  Nitric oxide antagonist
0,579  0,014  Cytotoxic
0,567  0,014  Antineoplastic (pancreatic cancer)
0,537  0,001  Retinoid X beta receptor agonist
0,566  0,030  Antineoplastic (solid tumors)
0,562  0,029  Antileukemic
0,523  0,001  Retinoid X gamma receptor agonist
0,529  0,013  Free radical scavenger
0,526  0,015  Antineoplastic (multiple myeloma)
0,525  0,018  Hepatic disorders treatment
0,507  0,000  Retinoid X gamma receptor antagonist
0,515  0,011  Vascular (periferal) disease treatment
0,511  0,014  Hypoglycemic
0,495  0,002  Transcription factor AP-1 inhibitor
0,502  0,016  Antiprotozoal (Leishmania)
0,480  0,002  Keratolytic
0,487  0,010  Antineoplastic (renal cancer)
0,479  0,008  UGT1A3 substrate
0,503  0,032  Immunosuppressant
0,470  0,004  CYP2B6 inhibitor
0,503  0,040  Antibacterial
0,487  0,024  Cardioprotectant
0,468  0,006  UGT2B7 substrate
0,480  0,030  Antineoplastic (ovarian cancer)
0,449  0,013  Antiulcerative
0,468  0,033  Immunostimulant
0,447  0,013  Antineoplastic (small cell lung cancer)
0,435  0,004  Antinephritic
0,455  0,031  Antifungal
0,425  0,003  Growth stimulant
0,448  0,028  Antineoplastic (non-Hodgkin's lymphoma)
0,401  0,005  Retinopathy treatment
0,404  0,018  Wound healing agent
0,441  0,055  GST A substrate
0,378  0,004  Age-related macular degeneration treatment
0,356  0,003  Actinic keratosis treatment
0,393  0,043  ICAM1 expression inhibitor
0,386  0,042  Lipoprotein disorders treatment
0,381  0,044  Antineoplastic (melanoma)
0,352  0,027  Antineoplastic enhancer
0,328  0,007  Aldose reductase substrate
0,355  0,038  Antihypoxic
0,358  0,044  Antineoplastic (glioma)
0,322  0,009  Cocaine dependence treatment
0,311  0,002  Retinoid X alpha receptor agonist
0,377  0,071  Antineoplastic (lung cancer)
0,302  0,002  Retinoid X receptor agonist
0,337  0,038  Antineoplastic (glioblastoma multiforme)
0,378  0,084  15-Lipoxygenase inhibitor
0,309  0,018  Lipid peroxidase inhibitor
0,325  0,036  DNA synthesis inhibitor
0,301  0,013  Phospholipase A2 inhibitor
0,288  0,003  Adenylate cyclase stimulant
0,314  0,029  Platelet adhesion inhibitor
0,331  0,048  NOS2 expression inhibitor
0,331  0,049  Antineoplastic (osteosarcoma)
0,337  0,055  Lipoxygenase inhibitor
0,331  0,050  Antineoplastic (cervical cancer)
0,280  0,011  LDLR expression enhancer
0,327  0,068  Apoptosis antagonist
0,283  0,024  Melanin inhibitor
0,302  0,048  Hypolipemic
0,265  0,013  Antineoplastic antibiotic
0,257  0,007  HDL-cholesterol increasing
0,290  0,049  Antineoplastic (bladder cancer)
0,249  0,010  Retinoprotector
0,261  0,026  Interferon gamma antagonist
0,240  0,006  TRPA1 agonist
0,252  0,024  Bone formation stimulant
0,242  0,032  Antineoplastic (squamous cell carcinoma)
0,260  0,051  Antihypertriglyceridemic
0,266  0,058  Antineoplastic (lymphocytic leukemia)
0,199  0,001  Retinoid X beta receptor antagonist
0,257  0,064  Antineoplastic (lymphoma)
0,226  0,038  Antiviral (Herpes)
0,236  0,053  Abortion inducer
0,300  0,124  Antiprotozoal
0,268  0,093  CTGF expression inhibitor
0,332  0,161  Caspase 9 stimulant
0,172  0,011  Factor V inhibitor
0,247  0,090  CYP1A2 inhibitor
0,196  0,041  ATPase inhibitor
0,252  0,098  Hypoxia-inducible factor 1 alpha inhibitor
0,201  0,048  Succinate dehydrogenase inhibitor
0,146  0,002  Retinoid X receptor antagonist
0,133  0,001  Retinoid X alpha receptor antagonist
0,209  0,078  VCAM1 expression inhibitor
0,182  0,052  Arachidonic acid antagonist
0,161  0,032  Microtubule formation inhibitor
0,166  0,039  Alkylator
0,193  0,069  Hepatoprotectant
0,186  0,075  Antihelmintic
0,134  0,027  Androgen antagonist
0,119  0,017  Na+ K+ transporting ATPase inhibitor
0,120  0,019  3C-Like protease (SARS coronavirus) inhibitor
0,193  0,092  Antiparasitic
0,113  0,012  CDC25B inhibitor
0,172  0,072  UGT1A4 substrate
0,116  0,018  Thioredoxin reductase inhibitor
0,218  0,122  Antineoplastic (colorectal cancer)
0,176  0,082  Systemic lupus erythematosus treatment
0,257  0,165  CYP2C19 inhibitor
0,200  0,108  Acute neurologic disorders treatment
0,107  0,015  Antiemphysemic
0,266  0,176  Transcription factor inhibitor
0,144  0,059  Farnesoid X receptor antagonist
0,200  0,117  Superoxide dismutase inhibitor
0,167  0,085  Antipruritic, non-allergic
0,203  0,121  Antineoplastic (colon cancer)
0,169  0,087  Antirickettsial
0,154  0,076  Restenosis treatment
0,132  0,055  Cholesterol synthesis inhibitor
0,176  0,102  Neurotrophic factor enhancer
0,106  0,032  Antibiotic
0,100  0,027  Lipase inhibitor
0,087  0,017  Exportin-1 inhibitor
0,103  0,036  ATPase (Vacuolar H+) inhibitor
0,145  0,077  Antiviral (Influenza A)
0,129  0,064  Cathepsin H inhibitor
0,079  0,016  Heme oxygenase stimulant
0,183  0,122  Cardiovascular analeptic
0,114  0,055  Electron transport complex I inhibitor
0,071  0,013  Pregnane X receptor antagonist
0,194  0,136  Respiratory analeptic
0,160  0,103  Antieczematic atopic
0,127  0,071  Alpha-N-acetylglucosaminidase inhibitor
0,137  0,084  Genotoxic
0,134  0,081  Antineoplastic (carcinoma)
0,068  0,017  Glucose-6-phosphate translocase inhibitor
0,218  0,168  FMO1 substrate
0,060  0,018  Factor III inhibitor
0,095  0,058  GST P1-1 substrate
0,111  0,077  Carcinogenic, group 3
0,048  0,016  Kainate receptor agonist
0,184  0,154  UGT1A9 substrate
0,133  0,104  Ca2+-transporting ATPase inhibitor
0,059  0,032  Protein 50S ribosomal subunit inhibitor
0,143  0,116  UGT2B10 substrate
0,095  0,070  Anabolic
0,155  0,133  Pneumotoxic
0,053  0,032  Anesthetic inhalation
0,185  0,164  UGT2B4 substrate
0,107  0,086  Shock treatment
0,162  0,143  Tumour necrosis factor alpha release inhibitor
0,092  0,073  UGT2B11 substrate
0,026  0,009  Vitamin D receptor antagonist
0,036  0,021  HMG CoA reductase inhibitor
0,049  0,035  Collagenase inhibitor
0,154  0,142  Antihypercholesterolemic
0,111  0,102  Antifungal enhancer
0,096  0,090  DNA polymerase I inhibitor
0,052  0,049  Postcoital contraceptive
0,032  0,029  Tubulin agonist
0,015  0,014  Vitamin D receptor agonist

